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Abstract
Background: Total knee arthroplasty (TKA) is a common form of treatment to relieve pain and improve function in
cases of rheumatoid arthritis (RA). Good clinical outcomes have been reported with a variety of TKA prostheses.
The cementless Hi-Tech Knee II cruciate-retaining (CR)-type prosthesis, which has 6 fins at the anterior of the
femoral component, posterior cruciate ligament (PCL) retention, flat-on-flat surface component geometry, all-
polyethylene patella, strong initial fixation by the center screw of the tibial base plate, 10 layers of titanium alloy
fiber mesh, and direct compression molded ultra high molecular weight polyethylene (UHMWPE), is appropriate for
TKA in the Japanese knee.
The present study was performed to evaluate the clinical results of primary TKA in RA using the cementless Hi-
Tech Knee II CR-type prosthesis.
Materials and methods: We performed 32 consecutive primary TKAs using cementless Hi-Tech Knee II CR-type
prosthesis in 31 RA patients. The average follow-up period was 8 years 3 months. Clinical evaluations were
performed according to the American Knee Society (KS) system, knee score, function score, radiographic evaluation,
and complications.
Results: The mean postoperative maximum flexion angle was 115.6°, and the KS knee score and function score
improved to 88 and 70 after surgery, respectively. Complications, such as infection, occurred in 1 patient and
revision surgery was performed. There were no cases of loosening in this cohort, and prosthesis survival rate was
96.9% at 12 years postoperatively.
Conclusion: These results suggest that TKA using the cementless Hi-Tech Knee II CR-type prosthesis is a very
effective form of treatment in RA patients at 5 to 12 years postoperatively. Further long-term follow-up studies are
required to determine the ultimate utility of this type of prosthesis.
Background
The affected joints in patients with rheumatoid arthritis
(RA) show chronic proliferative synovitis, which has
been implicated in the destruction of articular cartilage
and bone, resulting in joint disability [1]. Good clinical
results of total knee arthroplasty (TKA) in patients with
RA have been reported using several types of prosthesis
[2-5]. The decisions regarding whether the posterior
cruciate ligament (PCL) should be replaced or retained
and whether the prosthesis should be fixed using
cement or not are made at the surgeon’s discretion.
Long-term (≥ 10 years) follow-up studies of cruciate-
retaining (CR) TKA without cement fixation of the
prosthesis in patients with RA have indicated prosthesis
survival rates of over 90% [6-8].
Hi-Tech Knee II CR-type cementless TKA (Naka-
shima Medical, Okayama, Japan) was developed in 1994
at Chiba University and is currently in clinical use, hav-
ing been applied in more than 1600 cases to date (Fig-
ure 1A-D). This prosthesis is an appropriate design for
the Japanese knee, with 6 fins at the anterior of the
femoral component, PCL retention, flat-on-flat surface
component geometry, all-polyethylene patella fixed with-
out cement, strong initial fixation by the center screw of
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Figure 1 A: Anterior view of the Hi-tech knee II prosthesis CR type component. Note the polyethylene geometry with flat surface. B:
Posterior view of the Hi-tech knee II prosthesis CR type component. Femoral component demonstrating the porous titanium coating and have
6 fins at anterior portion. C: Anteroposterior radiograph of Hi-tech knee II prosthesis CR type. D: Lateral radiograph of Hi-tech knee II prosthesis
CR type.
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the tibial base plate, 10 layers of titanium alloy fiber
mesh, and direct compression molded ultra high mole-
cular weight polyethylene (UHMWPE).
The present study was performed to evaluate the mid-
term (5-12 year) results of Hi-Tech Knee II CR-type
cementless TKA in patients with RA. This is the first
report of the mid-term results regarding the use of this
prosthesis.
All patients gave their informed consent prior inclu-
sion in the study.
Materials and methods
Patients
Thirty-two Hi-Tech Knee II CR-type cementless primary
TKAs were performed at our institution in 31 RA
patients between April 1998 and August 2005. The
study population consisted of 30 women and 1 man
with a mean age of 64.4 years (range: 39-78 years) at
surgery. The mean body mass index of the 31 patients
was 25.5 (range: 20.5-32.3). The average follow-up per-
iod was 8 years 3 months (range: 5 year 3 months-12
years 3 months).
All patients fulfilled the diagnostic criteria of the
American College of Rheumatology (ACR) [9], and had
Larsen grade IV or V radiographic involvement at sur-
gery [10]. The mean duration was 13.5 years (range: 5-
32 years). Twenty-three patients (74%) were receiving
active oral steroid therapy, and the average steroid dose
was 4.8 mg (range: 1-15 mg) daily.
This prosthesis was not indicated for use in cases with
revision surgery, mutilating type RA, absent or attenu-
ated PCL was observed in operation, severe deformity
(lower limb AP varus or valgus alignment > 30°), severe
knee stiffness (range of knee movement arc < 50°), or
severe instability of the knee (varus or valgus instability
> 30°, posterior sagging instability). We did not consider
metaphyseal defects of the tibia as a contraindication for
use of this prosthesis.
Surgical technique
A midline, longitudinal skin incision was used and the
joint was opened through the median parapatellar
approach. The PCL was preserved in all cases. Synovium
existing to the suprapatellar pouch, around the cruciate
ligaments, bilateral gutter, and posterior capsule were
resected as much as possible. Bone cuts were made
using an intramedullary guide on both the femur and
tibia oriented by the measured cut technique. Cancel-
lous bone chips were used to fill any bony defects and
the tibial component was fixed with three screws to
ensure initial stability. All patellae were also fixed with
all-polyethylene components without cement. All proce-
dures were performed with use of a tourniquet. Post-
operative antibiotic (cefazolin sodium) was administered
four times in 2 days. All patients received the same
deep vein thrombosis prophylaxis using 100 mg of acet-
ylsalicylic acid for 7 days.
Postoperative care
Range of motion exercise and full weight-bearing trans-
fer to a wheelchair were begun on the second post-
operative day, and full weight-bearing walking exercise
was started on the fifth day. Patients were discharged
when they could walk with a T-cane and tolerate stair
climbing.
Methods and evaluation
Patients were evaluated preoperatively and postopera-
tively by one of two senior joint replacement surgeons
(HY, KG) independent of the surgeon performing the
operation at 4 weeks, 6 months, and 1 year, and then
every 1 year thereafter.
Clinical evaluations were performed according to the
Knee Society (KS) system [11], which separately assesses
the mechanical and functional aspects of the knee joint.
Final follow-up standard anteroposterior and lateral
radiographs were evaluated for loosening, radiolucent
line, and subsidence according to the method of the
Knee Society roentgenographic evaluation and score sys-
tem [12]. The radiographs were taken according to the
standard protocol described previously [13]. Weight-
bearing anteroposterior (AP), lateral, and skyline image
radiographs were taken before and after the operation.
The femorotibial angle (FTA) of the knee was evaluated
on AP weight-bearing radiographs. Radiolucencies were
measured according to the zone described by the Knee
Society (Figure 2A-C). AP and mediolateral instability
were evaluated at each visit.
Complications, including infection, fracture, etc., were
also assessed. Statistical analysis was performed using
the paired t test for comparison of preoperative and
postoperative Knee Society scores.
We calculated prosthesis survival according to the
Kaplan-Meier method using revision for any cause, revi-
sion attributable to loosening, or infection [14].
Results
Clinical results
The average Knee Society knee rating score improved
from 32 (range: 20-65) preoperatively to 88 (range: 44-
96) at final follow-up evaluation. The average Knee
Society function score was 41 (range: 25-93) preopera-
tively, and also improved to 70 (range: 50-95) at final
follow-up. None of the patients showed posterior trans-
lation of the tibia of greater than 10 mm in the poster-
ior drawer test. Twenty-six knees (79%) were pain-free
and 7 knees (21%) had mild or occasional pain
postoperatively.
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Ten patients could walk for 30 to 60 min, 17 for 30 to
60 min, and 6 for less than 10 min. Eleven patients
required no walking aid, while 17 patients used walking
aids outdoors, and 5 patients required them perma-
nently. The mean preoperative maximum flexion angle
was 105.4°, and that postoperatively at the latest follow-
up was 115.6° (P < 0.05). Maximum extension angles
were -12.5° and -3.3°, respectively (P < 0.005). Good val-
gus-varus stability was maintained throughout the fol-
low-up period.
Radiographic results
All 32 patients in whom radiographic follow-up was per-
formed were assessed for radiolucency at the bone-
implant interface. Fourteen radiolucencies were identified
(44%): 5 were seen at the femoral component (zone 1: 3
knees; zone 4: 1 knee; zone 5: 1 knee) and 9 were at the
tibial component (AP view, zone 1: 5 knees; zone 3: 4
knees; lateral view, none). All measured less than 1 mm
distance and were non-progressive. No radiolucent line
was seen in the patella component, and there was no evi-
dence of radiographic loosening at follow-up. Subsi-
dences were detected in 7 knees (22%), but none were
progressive. The subsidence may have been due to incor-
rect cutting of the tibial bone or poor bone strength.
The average postoperative FTA alignment was 174.7°
(range: 170°-178°), and we found no differences in align-
ment throughout the follow-up period.
Complications
Complications occurred in two knees (6.1%): early deep
infection in one knee and supracondylar fracture of the
femur in the other. The case of infection required
revision surgery, while the case of fracture was healed
by conservative treatment.
There were no cases of late deep infection, nerve
palsy, pulmonary embolism, deep vein thrombosis, or
patella fracture.
Prosthetic survival rate was 96.9% at 12 years post-
operatively (95% confidence interval [CI], 86.6%-100%).
Discussion
TKA is a reliable form of treatment to relieve pain and
improve function in patients with RA. Factors that influ-
ence prosthetic survival include the design of the com-
ponent, the method of fixation (cemented or
cementless), and the preservation or excision of the PCL
[15-18]. It remains unclear whether it is best to retain
or excise the PCL, and whether cement should or
should not be used for implant fixation.
There have been several reports describing good long-
term results of cementless TKA for RA, with prosthetic
survival rate of over 90% with follow-up periods of more
than 10 years [2-5]. However, there have been few
reports regarding the long-term outcome of cementless
CR-type TKA [6-8]. The results of the present study
suggested that the clinical results of Hi-Tech Knee II
CR-type cementless TKA in RA patients are satisfactory.
Cement has disadvantages related to toxicity [19],
reduced bone stock at revision, and difficulty in treating
infections [20]. However, early fixation after cementless
TKA is the main problem related to stability of the
prosthesis compared with cemented fixation [21]. The
Hi-Tech Knee II CR-type component is coated with
fiber mesh consisting of ten layers of titanium, designed
to promote mechanical fixation by bone ingrowth [22].
The radiolucent line indicates the results of incorrect
cutting of the femur and tibia. The width of this line is
not progressive, and none of the patients in the present
study had loosening, suggesting that adequate fixation
can be achieved due to bony ingrowth.
The choice of whether to use a PCL-retaining design
or posterior-stabilized design for TKA is based on lim-
ited data. It has been reported that there are no differ-
ence in clinical outcome between PCL retention and
PCL removal, and conversely that the PS design results
in a better range of motion and easier operation techni-
que. Conditt [23] reported that substitution of the PCL
with a spine and cam mechanism may not fully restore
the functional capacity of the PCL, particularly in high-
demand activities that involve deep flexion, squatting,
kneeling, and gardening.
PCL substitution is believed to prevent posterior sub-
luxation of the tibia in addition to enhancing roll-back
during deep knee flexion. It has been suggested that
PCL substitution allows greater conformity, which in




Figure 2 The Knee Society Roentgenographjc Evaluation
System. A: Anteroposterior view of representative tibial component.
B: Lateral view of representative tibial component. C: Lateral view of
representative femoral component.
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plate. In this study, there were no cases of subluxation
or loosening of the tibial base plate. Shai [24] reported
the prosthesis survival rate of 97% at 13 years in the
PCL-retaining procedure, and Rodriguez [25] also
reported the rate of 91% at 15 years.
The disease state of the RA knee at the time of
arthroplasty dictates whether the PCL is retained or
sacrificed and whether cement is or is not used. There-
fore, we did not use this prosthesis for all RA knees.
The contraindications for use of this prosthesis include
cases with mutilating type RA, severe deformity, severe
knee stiffness, and severe instability of the knee. We did
not consider metaphyseal tibial defect as a contraindica-
tion for use of this prosthesis.
There were some limitations in this study. First, this
study was performed in a select patient population, and
selection bias may have influenced the clinical out-
comes. Second, the number of patients was small, which
may have led to small-sample bias. Third, we did not
perform blinded radiographic analysis. Fourth, the fol-
low-up period was relatively short. Finally, this was a
retrospective study.
In this study, there were no indications of problems
associated with retention of the PCL and cementless
fixation. However, attention should be paid to cases
with large bony defects of the knee and with mutilating
types of joint destruction. Appropriate selection of
patient, prosthesis, and operative technique may lead to
good clinical results, even using a CR-type prosthesis
and cementless fixation.
Conclusions
Although some concerns still remain, the satisfactory
clinical and radiological results of the present study 5-12
years postoperatively support the use of this prosthesis
in cases of RA. However, the results did not suggest
that this prosthesis is superior to other cemented and
PS type prostheses for RA patients. The ultimate utility
of this type of prosthesis should be judged based only
on its long-term clinical outcome, and further studies
are therefore required.
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